Literature DB >> 12435396

Enhanced expression of the human chitinase 3-like 2 gene (YKL-39) but not chitinase 3-like 1 gene (YKL-40) in osteoarthritic cartilage.

Eric Steck1, Stephen Breit, Steffen J Breusch, Matthias Axt, Wiltrud Richter.   

Abstract

The knowledge of molecular alterations in osteoarthritic cartilage is important to identify novel therapeutic targets or to develop new diagnostic tools. We aimed to characterize the molecular response to cartilage degeneration by identification of differentially expressed genes in human osteoarthritic versus normal cartilage. Gene fragments selectively amplified in osteoarthritic cartilage by cDNA representational difference analysis included YKL-39 and the oesophageal-cancer-related-gene-4 (ECRG4). YKL-39 expression was significantly upregulated in cartilage from patients with osteoarthritis (n=14) versus normal subjects (n=8) according to real-time PCR (19-fold, p=0.009) and cDNA array analysis (mean 15-fold, p<0.001) and correlated with collagen 2 up-regulation. In contrast, the homologous cousin molecule YKL-40 (chitinase 3-like 1), which is elevated in serum and synovial fluid of patients with arthritis, showed no significant regulation in OA cartilage. Enhanced levels of YKL-40 may, therefore, be derived from synovial cells while modulation of YKL-39 and collagen 2 expression reflected the cartilage metabolism in response to degradation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12435396     DOI: 10.1016/s0006-291x(02)02585-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  31 in total

1.  Cell surface localization and release of the candidate tumor suppressor Ecrg4 from polymorphonuclear cells and monocytes activate macrophages.

Authors:  Andrew Baird; Raul Coimbra; Xitong Dang; Nicole Lopez; Jisook Lee; Michael Krzyzaniak; Robert Winfield; Bruce Potenza; Brian P Eliceiri
Journal:  J Leukoc Biol       Date:  2012-03-06       Impact factor: 4.962

2.  Human cartilage chitinase 3-like protein 2: cloning, expression, and production of polyclonal and monoclonal antibodies for osteoarthritis detection and identification of potential binding partners.

Authors:  Araya Ranok; Panida Khunkaewla; Wipa Suginta
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2013-10

3.  Soluble purified recombinant C2ORF40 protein inhibits esophageal cancer cell proliferation by inducing cell cycle G1 phase block.

Authors:  Xiaoyan Li; Linwei Li; Wenyu Wang; Yang Yang; Yun Zhou; Shixin Lu
Journal:  Oncol Lett       Date:  2015-06-26       Impact factor: 2.967

4.  Distinct degenerative phenotype of articular cartilage from knees with meniscus tear compared to knees with osteoarthritis.

Authors:  M F Rai; E D Tycksen; L Cai; J Yu; R W Wright; R H Brophy
Journal:  Osteoarthritis Cartilage       Date:  2019-02-21       Impact factor: 6.576

5.  Soluble purified recombinant C2ORF40 protein inhibits tumor cell growth in vivo by decreasing telomerase activity in esophageal squamous cell carcinoma.

Authors:  Linwei Li; Xiaoyan Li; Wenyu Wang; Tianhui Gao; Yun Zhou; Shixin Lu
Journal:  Oncol Lett       Date:  2016-08-02       Impact factor: 2.967

6.  Human chitinases and chitinase-like proteins as indicators for inflammation and cancer.

Authors:  Julia Kzhyshkowska; Alexei Gratchev; Sergij Goerdt
Journal:  Biomark Insights       Date:  2007-05-03

Review 7.  Production of chitooligosaccharides and their potential applications in medicine.

Authors:  Berit B Aam; Ellinor B Heggset; Anne Line Norberg; Morten Sørlie; Kjell M Vårum; Vincent G H Eijsink
Journal:  Mar Drugs       Date:  2010-04-27       Impact factor: 5.118

8.  Overexpression of candidate tumor suppressor ECRG4 inhibits glioma proliferation and invasion.

Authors:  Wei Li; Xinrui Liu; Bo Zhang; Dongxue Qi; Lihong Zhang; Yuhong Jin; Hongfa Yang
Journal:  J Exp Clin Cancer Res       Date:  2010-07-04

9.  C2ORF40 suppresses breast cancer cell proliferation and invasion through modulating expression of M phase cell cycle genes.

Authors:  Jing Lu; Mingxin Wen; Yurong Huang; Xiuquan He; Yunshan Wang; Qi Wu; Zengchun Li; Andres Castellanos-Martin; Mar Abad; Juan J Cruz-Hernandez; Cesar A Rodriguez; Jesús Pérez-Losada; Jian-Hua Mao; Guangwei Wei
Journal:  Epigenetics       Date:  2013-04-26       Impact factor: 4.528

10.  Down-regulated ECRG4 expression in breast cancer and its correlation with tumor progression and poor prognosis--A short Report.

Authors:  Yanjie You; Haijun Li; Xin Qin; Yonggang Ran; Fei Wang
Journal:  Cell Oncol (Dordr)       Date:  2015-12-02       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.